EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparative Analysis of Signet Ring and Non-Signet Ring Urachal Adenocarcinomas: A National Cancer Database Study

Deerush Kannan Sakthivel, Pushan Prabhakar, Mohamed Javid Raja Iyub, Rohan Garje, Murugesan Manoharan

Clinical Genitourinary Cancer · 2026

DOI: 10.1016/j.clgc.2025.102495 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Clinical Genitourinary Cancer, 2026. Verfasst von Deerush Kannan Sakthivel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urologic Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL. Electronic address: deerush92@gmail.com. Hauptthemen laut MEDLINE: Carcinoma, Signet Ring Cell, Urinary Bladder Neoplasms, Cystectomy, Adenocarcinoma. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Primary urachal adenocarcinomas are rare and histologically diverse. Signet ring cell carcinoma (SRCC), a poorly cohesive and aggressive variant, is associated with poor prognosis compared to non-signet ring urachal adenocarcinoma (UA). This study aims to compare the clinicopathologic features, treatment patterns, and survival outcomes between SRCC and UA. METHODS: We retrospectively analyzed data from the National Cancer Database (2004-2020), including patients aged ≥ 18 with SRCC or non-signet ring UA located at the bladder dome. Demographics, staging, treatment modalities, and overall survival (OS) were compared using chi-square tests and Kaplan-Meier analysis. RESULTS: Among 550 patients, 60 had SRCC and 490 had non-signet ring UA. Baseline characteristics were comparable, though SRCC cases showed more frequent under-staging and treatment at community centers. Median OS was significantly shorter for SRCC (29.6 vs. 79.0 months, P < .001). Partial cystectomy conferred better survival than radical cystectomy in both groups. Chemotherapy did not improve outcomes in SRCC and was associated with worse survival in UA, likely due to selection bias. CONCLUSION: SRCC of the urachus is a biologically distinct subtype with significantly worse outcomes than non-signet ring UA, regardless of surgical approach. Histology-specific strategies are needed to improve survival in this rare, aggressive cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Signet Ring CellUrinary Bladder NeoplasmsCystectomyAdenocarcinomaHumansFemaleRetrospective StudiesMaleMiddle AgedAgedDatabases, FactualPrognosisAdultNeoplasm Staging

Stichwörter der Autor:innen

Partial cystectomyRadical cystectomySignet ring urachal cancerUrachal cancer

Autor:innen und Institutionen

  • Department of Urologic Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL. Electronic address: deerush92@gmail.com.
  • Department of Urologic Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL.

Zitieren

APA

Sakthivel, D. K., Prabhakar, P., Iyub, M. J. R., Garje, R., & Manoharan, M. (2026). Comparative Analysis of Signet Ring and Non-Signet Ring Urachal Adenocarcinomas: A National Cancer Database Study. Clinical Genitourinary Cancer. https://doi.org/10.1016/j.clgc.2025.102495

Vancouver

Sakthivel DK, Prabhakar P, Iyub MJR, Garje R, Manoharan M. Comparative Analysis of Signet Ring and Non-Signet Ring Urachal Adenocarcinomas: A National Cancer Database Study. Clinical Genitourinary Cancer. 2026. doi:10.1016/j.clgc.2025.102495

BibTeX
@article{Sakthivel2026,
  author = {Sakthivel, Deerush Kannan and Prabhakar, Pushan and Iyub, Mohamed Javid Raja and Garje, Rohan and Manoharan, Murugesan},
  title = {Comparative Analysis of Signet Ring and Non-Signet Ring Urachal Adenocarcinomas: A National Cancer Database Study},
  journal = {Clinical Genitourinary Cancer},
  year = {2026},
  doi = {10.1016/j.clgc.2025.102495}
}
Kostenlos starten →